Maexeni 30 Mite

Ethinylestradiol and Levonorgestrel, the active ingredients in Maexeni 30 Mite, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age. GNH USA supplies Maexeni 30 Mite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maexeni 30 Mite is a combined oral contraceptive that acts on the reproductive hormone pathway to prevent pregnancy. - Contraception: provides reliable prevention of pregnancy for women of child‑bearing age. - Menstrual cycle regulation: helps achieve more predictable menstrual bleeding patterns. - Hormonal acne management: may improve moderate acne associated with androgen excess.

Maexeni 30 Mite may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: temporary swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding. - Weight change: slight increase or decrease. - Mood changes: irritability or mood swings.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in legs. - Pulmonary embolism: clot migration to lungs. - Stroke or transient ischemic attack. - Hepatic adenoma or other liver tumors. - Severe allergic reaction: rash, swelling, anaphylaxis. - Hypertension: significant rise in blood pressure.

Before prescribing Maexeni 30 Mite, clinicians should evaluate individual risk factors and counsel patients on safe use. - Cardiovascular assessment: avoid in women with history of thromboembolic disease. - Smoking restriction: do not smoke if over 35 years of age. - Liver function: contraindicated in severe hepatic impairment. - Blood pressure monitoring: check regularly during therapy. - Missed dose guidance: provide clear instructions for forgotten tablets. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Maexeni 30 Mite can interact with several medicines that alter hormone metabolism or increase clotting risk.

Major Interactions (Avoid): - Rifampin and other potent enzyme inducers: reduce contraceptive efficacy. - Antiepileptic drugs (carbamazepine, phenytoin, phenobarbital): lower hormone levels. - St. John's Wort: may diminish contraceptive effect. - Certain HIV protease inhibitors: unpredictable hormone concentrations. - Griseofulvin: decreases oral contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Antifungal agents (ketoconazole, itraconazole): may increase hormone levels. - Selective serotonin reuptake inhibitors: potential for increased bleeding. - Diuretics (thiazides): may affect fluid balance. - Antihypertensives (ACE inhibitors): monitor blood pressure. - Herbal supplements (ginkgo biloba): watch for additive clotting effects.